Adherence and/or discontinuation of imatinib mesylate in patients with chronic myeloid leukemia

ABSTRACT Adherence to imatinib mesylate improves clinical outcomes and promotes a reduction in health expenditure. However, treatment duration and lack of efficacy decrease adherence to pharmacotherapy, resulting in increased mortality associated with Chronic Myeloid Leukemia. This study aimed to ev...

Full description

Bibliographic Details

Published in:	Brazilian Journal of Pharmaceutical Sciences
Main Authors:	Alexandra Rodrigues Alves, William Gustavo Lima, Michelly Martins Nagai, João Paulo Vilela Rodrigues, Lorena Rocha Ayres
Format:	Article
Language:	English
Published:	Universidade de São Paulo
Subjects:	Chronic Myeloid Leukemia/treatment Imatinib Mesylate/treatment adherence Medication adherence Pharmacotheraphy review.
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502016000400581&lng=en&tlng=en